Clinical Trials, Cancer Research
- FREI E, 3rd, HOLLAND JF, SCHNEIDERMAN MA, PINKEL D, SELKIRK G, FREIREICH EJ, SILVER RT, GOLD GL, REGELSON W. A comparative study of two regimens of combination chemotherapy in acute leukemia. Blood. 1958 Dec;13(12):1126–1148.
- Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612.
- Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975 Mar;31(1):103–115.
- George SL, Desu MM. Planning the size and duration of a clinical trial studying the time to some critical event. J Chronic Dis. 1974 Feb;27(1):15–24.
- Byar DP, Simon RM, Friedewald WT, Schlesselman JJ, DeMets DL, Ellenberg JH, Gail MH, Ware JH. Randomized clinical trials. Perspectives on some recent ideas. N Engl J Med. 1976 Jul 8;295(2):74–80.
- Shaw LW, Chalmers TC. Ethics in cooperative clinical trials. Ann N Y Acad Sci. 1970 Jan 21;169(2):487–495.
- Gehan EA, Freireich EJ. Non-randomized controls in cancer clinical trials. N Engl J Med. 1974 Jan 24;290(4):198–203.
- Atkins H. Conduct of a controlled clinical trial. Br Med J. 1966 Aug 13;2(5510):377–379.
- Pocock SJ. The combination of randomized and historical controls in clinical trials. J Chronic Dis. 1976 Mar;29(3):175–188.
- BULL JP. The historical development of clinical therapeutic trials. J Chronic Dis. 1959 Sep;10:218–248.
- Cutler SJ, Greenhouse SW, Cornfield J, Schneiderman MA. The role of hypothesis testing in clinical trials. Biometrics seminar. J Chronic Dis. 1966 Aug;19(8):857–882.
- Tukey JW. Some thoughts on clinical trials, especially problems of multiplicity. Science. 1977 Nov 18;198(4318):679–684.
You might also like
The CRA's Guide to Monitoring Clinical Research, Third Edition
Are clinical trials (research studies) available for people with bone cancer?
Yes. Participation in clinical trials is an important treatment option for many people with bone cancer. To develop new treatments and better ways to use current treatments, NCI, a part of the National Institutes of Health, is sponsoring clinical trials in many hospitals and cancer centers around the country. Clinical trials are a critical step in the development of new methods of treatment. Before any new treatment can be recommended for general use, doctors conduct clinical trials to find out whether the treatment is safe for patients and effective against the disease.